Company Quick10K Filing
Chase General
10-Q 2020-12-31 Filed 2021-02-12
10-Q 2020-09-30 Filed 2020-11-13
10-K 2020-06-30 Filed 2020-09-24
10-Q 2020-03-31 Filed 2020-05-14
10-Q 2019-12-31 Filed 2020-02-12
10-Q 2019-09-30 Filed 2019-11-14
10-K 2019-06-30 Filed 2019-09-30
10-Q 2019-03-31 Filed 2019-05-15
10-Q 2018-12-31 Filed 2019-02-14
10-Q 2018-09-30 Filed 2018-11-13
10-K 2018-06-30 Filed 2018-09-26
10-Q 2018-03-31 Filed 2018-05-14
10-Q 2017-12-31 Filed 2018-02-12
10-Q 2017-09-30 Filed 2017-11-13
10-K 2017-06-30 Filed 2017-09-27
10-Q 2017-03-31 Filed 2017-05-12
10-Q 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-10
10-K 2016-06-30 Filed 2016-09-23
10-Q 2016-03-31 Filed 2016-05-12
10-Q 2015-12-31 Filed 2016-02-12
10-Q 2015-09-30 Filed 2015-11-12
10-K 2015-06-30 Filed 2015-09-22
10-Q 2015-03-31 Filed 2015-05-08
10-Q 2014-12-31 Filed 2015-02-13
10-Q 2014-09-30 Filed 2014-11-12
10-K 2014-06-30 Filed 2014-09-18
10-Q 2014-03-31 Filed 2014-05-09
10-Q 2013-12-31 Filed 2014-02-07
10-Q 2013-09-30 Filed 2013-11-08
10-K 2013-06-30 Filed 2013-09-19
10-Q 2013-03-31 Filed 2013-05-10
10-Q 2012-12-31 Filed 2013-02-08
10-Q 2012-09-30 Filed 2012-11-09
10-K 2012-06-30 Filed 2012-09-14
10-Q 2012-03-31 Filed 2012-05-11
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-14
10-K 2011-06-30 Filed 2011-09-26
10-Q 2011-03-31 Filed 2011-05-17
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-15
10-K 2010-06-30 Filed 2010-09-27
10-Q 2010-03-31 Filed 2010-05-14
10-Q 2009-12-31 Filed 2010-02-12
8-K 2019-02-01
8-K 2018-03-19

Chase General Financials

CSGN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash29227168184134328429264393361622453305843037128319630012346532818520249991924
Accounts Receivable702184152140532253143167600243178179687269141188699175148180640307304127659187215135554187166138448
Inventory
PP&E4694444741,1804264053831,1221,1301,1371,1431,1441,1561,1671,1691,2221,2461,2471,2471,2501,2671,2671,2671,2671,2671,2641,2671,2321,2321,2321,2321,2281,228
Assets1,7861,2621,1761,0731,5981,2911,1141,0781,5291,2951,1531,1591,5101,3421,2461,2581,7491,3851,2091,2471,7561,2821,0421,0451,5091,1079138311,3159416917861,563
Accounts Payable3388911979294133416729611056523401054511233412641472881426964266157113177295924879266
Long-Term Debt1251131201069274544027116531815145063595551474339353128252219132017
Liabilities1,0193954163728864393173017403712863326473372762907843482502457823081832227422681952527351791122431,016
Stockholders' Equity8677607017128537977777899248668288621,0059709699651,0389591,002974974860823766839718578579762579543547
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue9061,2184284017981,4754524669111,4034624689921,2914514901,0631,2794774868621,1533983398701,1103787421,131327321714
Cost of Revenue714862393345584986353323658938373268715846357350843921437276672931409248661786344526752355239489
Gross Profit1923563557214489100143253464892002774459414022035840210190222-10912093243427215378-2882225
R&D
SG&A228232192141218257186177235256179178236240159157238252161159235219167150259241189170211193158133222
Tax-521-40-27590-31-16474-31-401778-18-162840-4370-0-701590-63-30
Net Income-35100-107-5911141-56-1911136-58-3935143-35-2-473-7943-28-0-114-36-5772-120-1401182-183-364
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-325565-26-176-271646-36-239-187653-74-161-273615-125-162-261576-85-257-284590-173-73-368658-133-144-322-140-162-194
Cash Investing-20022-20-2-8-13-6-1-11-22-20-14-80
Cash Financing336-364-1426271-342-24-15193-228-22-12123-142-3-4221-227-4-4288-296-4-4326-334-9320-1083199